1. Home
  2. RCAT vs ANNX Comparison

RCAT vs ANNX Comparison

Compare RCAT & ANNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Red Cat Holdings Inc.

RCAT

Red Cat Holdings Inc.

HOLD

Current Price

$11.16

Market Cap

957.4M

Sector

Industrials

ML Signal

HOLD

Logo Annexon Inc.

ANNX

Annexon Inc.

HOLD

Current Price

$5.64

Market Cap

918.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RCAT
ANNX
Founded
2002
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Wholesale Distributors
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
957.4M
918.2M
IPO Year
2017
2020

Fundamental Metrics

Financial Performance
Metric
RCAT
ANNX
Price
$11.16
$5.64
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
6
Target Price
$14.50
$16.50
AVG Volume (30 Days)
15.9M
2.3M
Earning Date
02-09-2026
03-02-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$7,443,942.00
N/A
Revenue This Year
$438.56
N/A
Revenue Next Year
$265.13
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.58
$1.29
52 Week High
$18.02
$7.18

Technical Indicators

Market Signals
Indicator
RCAT
ANNX
Relative Strength Index (RSI) 43.58 45.15
Support Level $12.78 $6.10
Resistance Level $14.52 $6.59
Average True Range (ATR) 1.85 0.43
MACD -0.56 -0.14
Stochastic Oscillator 4.80 10.57

Price Performance

Historical Comparison
RCAT
ANNX

About RCAT Red Cat Holdings Inc.

Red Cat Holdings Inc is a drone technology company integrating robotic hardware and software for military, government, and commercial operations. Red Cat's suite of solutions includes the Arachnid family of ISR and precision strike drones, which includes the Black Widow, a small unmanned ISR system; and WEB (Warfighter Electronic Bridge) GCS, designed to command and control an entire drone family of systems for military operations. Its other offerings include Edge 130 Blue drone systems, Trichon, a fixed-wing VTOL for extended endurance and range, and FANG FPV drones optimized for military operations with precision strike capabilities.

About ANNX Annexon Inc.

Annexon Inc is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye. Its pipeline is based on its platform technology addressing well-researched classical complement-mediated autoimmune and neurodegenerative disease processes, both of which are triggered by aberrant activation of C1q. Its pipeline of product candidates is designed to block the activity of C1q and the entire classical complement pathway in a broad set of complement-mediated diseases. Its product candidates are ANX005, for autoimmune & neurodegenerative disorders; ANX007, for neurodegenerative ophthalmic disorders; ANX1502 for Oral small molecule; and ANX009, for systemic autoimmune diseases.

Share on Social Networks: